[1] Abdel-ZaherAO,MostafaMG,FarghlyHM,et al.Inhibition of brain oxidative stress andinducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice[J].Eur Pharmacol,2013,702(1~3):62~70. [2] 赖长素,周培华.呋塞米联合脑钠肽在造影剂肾病的临床研究[J].中国临床药理学杂志,2015,31(22):2205~2207. [3] Moos SI,StokerJ,BeenenLF,et al.The prevention of contrast-induced nephropathy inDutch hospitals[J].Neth Med,2013,71(2):97~103. [4] Vasconcelos Rios ER,Moura Rocha NF,RodriguesCarvalhoAM,et al.Involvement of the Nitric Oxide/Cyclic Guanylate Monophosphate Pathway in the Pilocarpine-Induced Seizure Model in Mice[J].Pharmacology,2013,91(3~4):131-134. [5] Jorgensen AL.Contrast-induced nephropathy:pathophysiology and preventive strategies[J].Crit Care Nurse,2013,33(1):37~46. [6] MarkotaD,MarkotaI,StarcevicB,et al.Prevention of contrast-induced nephropathy withNa/K citrate[J].Eur Heart,2013,34(30):2362~2367. [7] Kodama A,WatanabeH,TanakaR,et al.A human serum albumin-thioredoxinfusionprotein prevents experimental contrast-induced nephropathy[J].Kidney Int,2013,83(3):446~454. [8] 陆静茹.血糖水平与冠状动脉介入治疗后造影剂肾病发生的相关性分析[J].社区医学杂志,2015,13(10):87~88 [9] 赵瑛瑛,欧阳军,王建生,等.血清胱抑素C检测在造影剂肾病早期诊断中的价值[J].郑州大学学报(医学版),2012,6(47):830~832. [10] 王金艳,陈红,丁文飞,等.造影剂肾病发病机制中炎症反应的探讨[J].中国病理生理杂志,2014,30(5):950~956. [11] 李明珠,张金盈,沈德良.冠状血管造影术前血浆氨基末端脑钠肽前体水平与造影剂肾病发生的相关性研究[J].中国全科医学,2014,17(3):278~281. [12] 崔巍.血清同型半胱氨酸和胱抑素C与2型糖尿病肾病的关系[D].吉林大学,2014. [13] 钟思干,杨飞,陈爱文,等.前列地尔对合并糖尿病的冠心病患者介入治疗中造影剂肾病的预防作用研究[J].中国全科医学,2014,17(31):3720~3723. [14] PyxarasSA,SinagraG,MangiacapraF,et al.Contrast-induced nephropathy in patientsundergoing primary percutaneous coronary intervention without acute left ventricular ejectionfraction impairment[J].Am Cardiol,2013,111(5):684~688. [15] Busch SV,JensenSE,RosenbergJ,et al.Prevention of Contrast-Induced Nephropathy inSTEMI Patients Undergoing Primary Percutaneous Coronary Intervention:A Systematic Review[J].Interv Cardiol,2013,26(1):97~105. [16] SeongJM,ChoiNK,LeeJ,et al.Comparison of the safety of seven iodinated contrast Media[J].Korean Med Sci.2013,28:1703~1710. [17] Fu N,LiX,YangS,et al.Risk score for the prediction of contrast-induced nephropathy inelderly patients undergoing percutaneous coronary intervention[J].Angiology,2013,64(3):188~194. [18] Raposeiras-RoubínS,Aguiar-SoutoP,Barreiro-PardalC,et al.GRACE risk score predictscontrast-induced nephropathy in patients with acute coronary syndrome and normal renal function[J].Angiology,2013,64(1):31~39 |